Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG).
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Swedish Inflammatory Bowel Disease Register (SWIBREG) – a nationwide quality register.
Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).
Sick leave and disability pension in prevalent patients with Crohn’s disease.
Work Loss Before and After Diagnosis of Crohn’s Disease.
Validating surgical procedure codes for inflammatory bowel disease in the Swedish National PatientRegister.
Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.